No abstract available
MeSH terms
-
Anticoagulants / adverse effects
-
Anticoagulants / therapeutic use*
-
Atrial Fibrillation / complications
-
Atrial Fibrillation / drug therapy*
-
Benzimidazoles / adverse effects
-
Benzimidazoles / therapeutic use
-
Dabigatran
-
Decision Support Techniques*
-
Health Status Indicators
-
Hemorrhage / chemically induced
-
Hemorrhage / prevention & control*
-
Humans
-
Morpholines / adverse effects
-
Morpholines / therapeutic use
-
Practice Guidelines as Topic
-
Pyrazoles / adverse effects
-
Pyrazoles / therapeutic use
-
Pyridones / adverse effects
-
Pyridones / therapeutic use
-
Risk Assessment
-
Rivaroxaban
-
Stroke / etiology
-
Stroke / prevention & control*
-
Thiophenes / adverse effects
-
Thiophenes / therapeutic use
-
Warfarin / adverse effects
-
Warfarin / therapeutic use
-
beta-Alanine / adverse effects
-
beta-Alanine / analogs & derivatives
-
beta-Alanine / therapeutic use
Substances
-
Anticoagulants
-
Benzimidazoles
-
Morpholines
-
Pyrazoles
-
Pyridones
-
Thiophenes
-
beta-Alanine
-
apixaban
-
Warfarin
-
Rivaroxaban
-
Dabigatran